API
IART icon

Advisor Partners II’s Integra LifeSciences IART Stock Holding History

Advisor Partners II’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$241K Buy
+6,308
New +$265K 0.01% 1075

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisor Partners II's IART Position: Q3 2023 in Review

Advisor Partners II opened a new position in Integra LifeSciences (IART) in Q3 2023: 6,308 shares worth $241K. The stake represents 0.01% of the portfolio and ranks #1075 among its holdings.

262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Advisor Partners II held 6,308 shares of Integra LifeSciences worth $241K as of Q3 2023.
  • Integra LifeSciences was a new Advisor Partners II position in Q3 2023.
  • Integra LifeSciences made up 0.01% of Advisor Partners II's portfolio in Q3 2023, its #1075 holding.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.